Metabolic pathways as possible therapeutic targets for progressive multiple sclerosis

Unlike relapsing remitting multiple sclerosis, there are very few therapeutic options for patients with progressive forms of multiple sclerosis. While immune mechanisms are key participants in the pathogenesis of relapsing remitting multiple sclerosis, the mechanisms underlying the development of pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Heidker, Rebecca M., Emerson, Mitchell R., LeVine, Steven M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Invited Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5607817/
https://www.ncbi.nlm.nih.gov/pubmed/28966637
http://dx.doi.org/10.4103/1673-5374.213542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5607817/
https://www.ncbi.nlm.nih.gov/pubmed/28966637
http://dx.doi.org/10.4103/1673-5374.213542

Ejemplares similares